GHRP-6 calculators

A 5 mg GHRP-6 vial mixed with 2 mL of bacteriostatic water gives 2.5 mg/mL — the same setup as GHRP-2. A 100 mcg dose pulls 4 units, which is borderline readable. Most experienced users mix with 1 mL instead to bump unit counts to 8.

One GHRP-6-specific failure mode worth knowing before you use the reconstitution math: Analyzing data on a day-to-day basis instead of observing the aggregate trends in appetite and sleep quality scores over a multi-week timeline. What do historical research studies indicate about cortisol and prolactin with GHRP-6? Scientific literature dating back to the 1980s consistently shows that GHRP-6 administration leads to measurable, dose-dependent increases in plasma cortisol and prolactin. This effect is significantly more pronounced than that observed with its successors, GHRP-2 and ipamorelin. In fact, the desire to reduce these off-target hormonal effects was a major driver behind the development of those later-generation peptides.

Vial size, diluent volume, and dose are the three inputs that genuinely change the answer. Doses-per-vial is a derived output — it's the vial mg divided by the dose mg, rounded down. The most common edge case is a tiny dose: at very high concentration, a 0.1 mL draw is only a few units on the syringe, which is hard to read accurately. If your unit count drops below five, consider reconstituting the next vial with more BAC water so each dose covers a larger volume.

Reconstitution is the process of dissolving the lyophilized powder into a liquid solution for measurement. The dose volume calculation requires three inputs: the total peptide mass in the vial, the volume of diluent added, and the target dose in micrograms. As a specific numeric example, if one reconstitutes a 5 mg vial of GHRP-6 with 2 mL of bacteriostatic water, the final concentration is 2,500 mcg per mL. To administer a 100 mcg dose from this solution, one would calculate that 0.04 mL is required (100 mcg dose / 2,500 mcg/mL), which converts to 4 units on a U-100 insulin syringe.

The volume of diluent used is a key variable in protocol design, as it presents a tradeoff between measurement convenience and dosing precision. Using a lower diluent volume, such as 1 mL per vial, results in a highly concentrated solution where each unit on a syringe represents a large quantity of peptide, potentially making small dose adjustments difficult. In contrast, using a higher diluent volume, like 4 mL, yields a less concentrated solution; this requires drawing a larger volume for a given dose but allows each unit on the syringe to represent a smaller microgram amount, facilitating finer control over the administered quantity.